Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer

Bibliographic Details
Title: Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
Authors: Fabienne Hamester, Christine Stürken, Karen Legler, Kathrin Eylmann, Katrin Möller, Maila Roßberg, Christian Gorzelanny, Alexander T. Bauer, Sabine Windhorst, Barbara Schmalfeldt, Elena Laakmann, Volkmar Müller, Isabell Witzel, Leticia Oliveira-Ferrer
Source: Cells, Vol 11, Iss 20, p 3275 (2022)
Publisher Information: MDPI AG, 2022.
Publication Year: 2022
Collection: LCC:Cytology
Subject Terms: breast cancer brain metastases, blood-brain barrier, pericellular Hyaluronan-coat, adhesion, invasion, Cytology, QH573-671
More Details: Breast cancer (BC) is the second-most common cause of brain metastases (BM) and BCBM patients have a reduced quality of life and a poor prognosis. Hyaluronan (HA), and in particular the hyaluronidase Hyal-1, has been already linked to the development of BCBM, and therefore presents an interesting opportunity to develop new effective therapeutic options. HA metabolism was further discovered by the CRISPR/Cas9-mediated knockout of HYAL1 and the shRNA-mediated down-regulation of HA-receptor CD44 in the brain-seeking triple-negative breast cancer (TNBC) cell line MDA-MB-231-BR. Therefore, the impact of Hyal-1 on adhesion, disruption, and invasion through the brain endothelium, both in vitro and in vivo, was studied. Our analysis points out a key role of Hyal-1 and low-molecular-weight HA (LMW-HA) in the formation of a pericellular HA-coat in BC cells, which in turn promotes tumor cell adhesion, disruption, and migration through the brain endothelium in vitro as well as the extent of BM in vivo. CD44 knockdown in MDA-MB-231-BR significantly reduced the pericellular HA-coat on these cells, and, consequently, tumor cell adhesion and invasion through the brain endothelium. Thus, the interaction between Hyal-1-generated LMW-HA fragments and the HA-receptor CD44 might represent a potential target for future therapeutic options in BC patients with a high risk of cerebral metastases formation.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2073-4409
Relation: https://www.mdpi.com/2073-4409/11/20/3275; https://doaj.org/toc/2073-4409
DOI: 10.3390/cells11203275
Access URL: https://doaj.org/article/f82c5d877d014fd1afcd83025381fe31
Accession Number: edsdoj.f82c5d877d014fd1afcd83025381fe31
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20734409
DOI:10.3390/cells11203275
Published in:Cells
Language:English